Madame Bioscience PCL (BKK:MADAME) Long-Term Debt: ฿143 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:MADAME Madame Bioscience PCL BKK:MADAME
21 GF Score
Price ฿1.02
GF Value ฿0.63
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Madame Bioscience PCL Long-Term Debt?

Madame Bioscience PCL BKK:MADAME +10.87% 21 Long-Term Debt is ฿143 Mil as of Mar. 2026. GuruFocus rates BKK:MADAME with a GF Score™ of 21/100 and a GF Value™ of ฿0.63 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Madame Bioscience PCL's Long-Term Debt for the quarter that ended in Mar. 2026 was ฿143 Mil.

Madame Bioscience PCL's quarterly Long-Term Debt increased from Sep. 2025 (฿0 Mil) to Dec. 2025 (฿141 Mil) and increased from Dec. 2025 (฿141 Mil) to Mar. 2026 (฿143 Mil).

Madame Bioscience PCL's annual Long-Term Debt declined from Dec. 2023 (฿103 Mil) to Dec. 2024 (฿41 Mil) but then increased from Dec. 2024 (฿41 Mil) to Dec. 2025 (฿141 Mil).

Madame Bioscience PCL  (BKK:MADAME) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Madame Bioscience PCL Long-Term Debt Related Terms

Madame Bioscience PCL Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Madame Bioscience PCL's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madame Bioscience PCL Long-Term Debt Chart

Madame Bioscience PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.27 456.24 102.81 40.90 141.22

Madame Bioscience PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 86.24 0.00 141.22 142.68
BKK:MADAME
21GF Score
Madame Bioscience PCL BKK:MADAME
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ฿143 Mil mean?
Madame Bioscience PCL (BKK:MADAME) has a Long-Term Debt of ฿143 Mil as of Mar. 2026.
Is Madame Bioscience PCL's Long-Term Debt too high?
Madame Bioscience PCL's current Long-Term Debt is ฿143 Mil. Overall, Madame Bioscience PCL has a GF Score™ of 21/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Madame Bioscience PCL's Long-Term Debt compare to KHC and GIS?
Madame Bioscience PCL's Long-Term Debt of ฿143 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Consumer Packaged Goods company?
A good Long-Term Debt depends on the Consumer Packaged Goods industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Madame Bioscience PCL's current Long-Term Debt is ฿143 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madame Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, Madame Bioscience PCL (BKK:MADAME) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.63, compared to a current price of ฿1.02 — trading 61.9% above its estimated fair value. The current Long-Term Debt is ฿143 Mil. Madame Bioscience PCL's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Madame Bioscience PCL (BKK:MADAME), the current Long-Term Debt is ฿143 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Madame Bioscience PCL (BKK:MADAME) Overvalued in 2026?

Based on GuruFocus' analysis, Madame Bioscience PCL stock appears to be overvalued. The current stock price of ฿1.02 is trading 61.9% above its estimated GF Value™ of ฿0.63. GuruFocus considers Madame Bioscience PCL to be Significantly Overvalued.

Key valuation signals for BKK:MADAME:

  • Long-Term Debt: ฿143 Mil
  • GF Value™: ฿0.63 vs. price of ฿1.02 (61.9% above fair value)
  • GF Score™: 21/100 with 3 warning signs

No single metric tells the full story. See the BKK:MADAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Madame Bioscience PCL Business Description

Address Praditmanutham Road, 60, 2nd Floor, Soi Praditmanutham 19, Lat Phrao, Lat Phrao, Bangkok, THA, 10230
Madame Bioscience PCL is engaged in the segments of the Packaging business, Food business, Retail sales of cosmetics, and Other businesses. Its activities include the manufacturing and selling of plastic packaging, restaurant business, advertising rental service in the gas station and manufacturing and selling of dried fruits, among others. The group derives a majority of its revenue from the Food business. The firm's product portfolio includes Ready meals, Frozen food, value-added seafood and vegetables, Flexible packaging, and PET Bottles.
21GF Score

Get the complete analysis for BKK:MADAME

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.02
Price
฿0.63
GF Value